PRX-3140, a 5-HT4 Partial Agonist and Sigma-1 Agonist/Antagonist, Modulates Glucocorticoid Insulin Suppression and Cortisol Levels

B.L. Hood, J.P. McLaughlin, A.R. Alleyne, J.S. Thinschmidt, S.W. Harden, C.J. Frazier, J.D. Talton
doi: https://doi.org/10.1101/2024.12.04.24318244

Article Information

doi 
https://doi.org/10.1101/2024.12.04.24318244
History 
  • December 12, 2024.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. B.L. Hood1,
  2. J.P. McLaughlin2,
  3. A.R. Alleyne2,
  4. J.S. Thinschmidt2,
  5. S.W. Harden2,
  6. C.J. Frazier2 and
  7. J.D. Talton1,*
  1. 1Alchem Laboratories Corp. / Nanopharmaceutics, Inc., Alachua FL
  2. 2Dept. of Pharmacodynamics, College of Pharmacy, Univ. of Florida, Gainesville, FL
  1. ↵*Correspondance:
    James D. Talton, Ph.D. Nanopharmaceutics, Inc. 14120 NW 126 Terrace, Alachua, FL 32615 jtalton{at}nanopharmaceutics.com
Back to top
Posted December 12, 2024.
Download PDF
Data/Code
Email
PRX-3140, a 5-HT4 Partial Agonist and Sigma-1 Agonist/Antagonist, Modulates Glucocorticoid Insulin Suppression and Cortisol Levels
B.L. Hood, J.P. McLaughlin, A.R. Alleyne, J.S. Thinschmidt, S.W. Harden, C.J. Frazier, J.D. Talton
medRxiv 2024.12.04.24318244; doi: https://doi.org/10.1101/2024.12.04.24318244
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area